• Je něco špatně v tomto záznamu ?

Focused HLA analysis in Caucasians with myositis identifies significant associations with autoantibody subgroups

S. Rothwell, H. Chinoy, JA. Lamb, FW. Miller, LG. Rider, LR. Wedderburn, NJ. McHugh, AL. Mammen, ZE. Betteridge, SL. Tansley, J. Bowes, J. Vencovský, CT. Deakin, K. Dankó, L. Vidya, A. Selva-O'Callaghan, LM. Pachman, AM. Reed, Ø. Molberg, O....

. 2019 ; 78 (7) : 996-1002. [pub] 20190528

Jazyk angličtina Země Velká Británie

Typ dokumentu časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc20006327

Grantová podpora
MR/K000608/1 Medical Research Council - United Kingdom
20380 Arthritis Research UK - United Kingdom
MR/N003322/1 Medical Research Council - United Kingdom
18474 Arthritis Research UK - United Kingdom
MR/S005021/1 Medical Research Council - United Kingdom
G0601943 Medical Research Council - United Kingdom

E-zdroje Online Plný text

NLK ProQuest Central od 1939-01-01 do Před 6 měsíci
Health & Medicine (ProQuest) od 1939-01-01 do Před 6 měsíci
Family Health Database (ProQuest) od 1939-01-01 do Před 6 měsíci

OBJECTIVES: Idiopathic inflammatory myopathies (IIM) are a spectrum of rare autoimmune diseases characterised clinically by muscle weakness and heterogeneous systemic organ involvement. The strongest genetic risk is within the major histocompatibility complex (MHC). Since autoantibody presence defines specific clinical subgroups of IIM, we aimed to correlate serotype and genotype, to identify novel risk variants in the MHC region that co-occur with IIM autoantibodies. METHODS: We collected available autoantibody data in our cohort of 2582 Caucasian patients with IIM. High resolution human leucocyte antigen (HLA) alleles and corresponding amino acid sequences were imputed using SNP2HLA from existing genotyping data and tested for association with 12 autoantibody subgroups. RESULTS: We report associations with eight autoantibodies reaching our study-wide significance level of p<2.9×10-5. Associations with the 8.1 ancestral haplotype were found with anti-Jo-1 (HLA-B*08:01, p=2.28×10-53 and HLA-DRB1*03:01, p=3.25×10-9), anti-PM/Scl (HLA-DQB1*02:01, p=1.47×10-26) and anti-cN1A autoantibodies (HLA-DRB1*03:01, p=1.40×10-11). Associations independent of this haplotype were found with anti-Mi-2 (HLA-DRB1*07:01, p=4.92×10-13) and anti-HMGCR autoantibodies (HLA-DRB1*11, p=5.09×10-6). Amino acid positions may be more strongly associated than classical HLA associations; for example with anti-Jo-1 autoantibodies and position 74 of HLA-DRB1 (p=3.47×10-64) and position 9 of HLA-B (p=7.03×10-11). We report novel genetic associations with HLA-DQB1 anti-TIF1 autoantibodies and identify haplotypes that may differ between adult-onset and juvenile-onset patients with these autoantibodies. CONCLUSIONS: These findings provide new insights regarding the functional consequences of genetic polymorphisms within the MHC. As autoantibodies in IIM correlate with specific clinical features of disease, understanding genetic risk underlying development of autoantibody profiles has implications for future research.

Ann and Robert H Lurie Children's Hospital of Chicago Northwestern University Feinberg School of Medicine Chicago Illinois USA

Arthritis Research UK Centre for Genetics and Genomics The University of Manchester Manchester UK

Center for Genomics and Human Genetics The Feinstein Institute for Medical Research Manhasset New York USA

Centre for Epidemiology The University of Manchester Manchester UK

Centre for Epidemiology The University of Manchester Manchester UK School of Healthcare Sciences Manchester Metropolitan University Manchester Greater Manchester UK

Centre for Genetics and Genomics Arthritis Research UK University of Manchester Manchester UK

Department of Internal Medicine and Clinical Immunology Pitié Salpêtrière University Hospital France France

Department of Neurology Ghent University Ghent Belgium

Department of Paediatrics and Adolescent Medicine Rigshospitalet Copenhagen Denmark

Department of Rheumatology and Clinical Immunology Utrecht Medical Center Utrecht The Netherlands

Department of Rheumatology University College London Hospital NHS Foundation Trust London UK Department of Rheumatology Northwick Park Hospital London North West University Healthcare NHS Trust London UK

Department of Rheumatology University of Oslo Oslo Norway

Division of Rheumatology Department of Medicine Karolinska University Hospital Stockholm Sweden

Division of Rheumatology University of Padova Padova Italy

Environmental Autoimmunity Group National Institute of Environmental Health Sciences Bethesda Maryland USA

Institute of Rheumatology and Department of Rheumatology Charles University Prague Czech Republic

Internal Medicine Department Vall d'Hebron General Hospital Universitat Autonoma de Barcelona Barcelona Spain

Internal Medicine University of Debrecen Debrecen Hungary

MRC ARUK Centre for Integrated Research into Musculoskeletal Ageing University of Liverpool Liverpool Merseyside UK

MRC Centre for Neuromuscular Diseases Department of Neuromuscular Diseases University College London Institute of Neurology London UK

Muscle Disease Unit Laboratory of Muscle Stem Cells and Gene Regulation National Institute of Musculoskeletal and Skin Diseases National Institutes of Health Bethesda Maryland USA Departments of Neurology and Medicine Johns Hopkins University School of Medicine Baltimore Maryland USA

National Institute for Health Research Manchester Biomedical Research Centre Central Manchester University Hospitals NHS Foundation Trust Manchester UK Manchester Academic Health Science Centre Salford Royal NHS Foundation Trust Salford UK

NIHR Great Ormond Street Biomedical Research Centre University College London London UK Arthritis Research UK Centre for Adolescent Rheumatology University College London London UK

Pediatrics Duke University Durham North Carolina USA

Pharmacy and Pharmacology University of Bath Bath UK

Pharmacy and Pharmacology University of Bath Bath UK Royal National Hospital for Rheumatic Diseases Royal United Hospitals Bath NHS Foundation Trust Bath UK

Rheumatology Unit Royal Adelaide Hospital University of Adelaide Adelaide South Australia Australia

Robert S Boas Center for Genomics and Human Genetics The Feinstein Institute for Medical Research Manhasset New York USA

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc20006327
003      
CZ-PrNML
005      
20200518132539.0
007      
ta
008      
200511s2019 xxk f 000 0|eng||
009      
AR
024    7_
$a 10.1136/annrheumdis-2019-215046 $2 doi
035    __
$a (PubMed)31138531
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxk
100    1_
$a Rothwell, Simon $u Centre for Genetics and Genomics, Arthritis Research UK, University of Manchester, Manchester, UK s.rothwell@manchester.ac.uk.
245    10
$a Focused HLA analysis in Caucasians with myositis identifies significant associations with autoantibody subgroups / $c S. Rothwell, H. Chinoy, JA. Lamb, FW. Miller, LG. Rider, LR. Wedderburn, NJ. McHugh, AL. Mammen, ZE. Betteridge, SL. Tansley, J. Bowes, J. Vencovský, CT. Deakin, K. Dankó, L. Vidya, A. Selva-O'Callaghan, LM. Pachman, AM. Reed, Ø. Molberg, O. Benveniste, PR. Mathiesen, TRDJ. Radstake, A. Doria, J. de Bleecker, AT. Lee, MG. Hanna, PM. Machado, WE. Ollier, PK. Gregersen, L. Padyukov, TP. O'Hanlon, RG. Cooper, IE. Lundberg, Myositis Genetics Consortium (MYOGEN),
520    9_
$a OBJECTIVES: Idiopathic inflammatory myopathies (IIM) are a spectrum of rare autoimmune diseases characterised clinically by muscle weakness and heterogeneous systemic organ involvement. The strongest genetic risk is within the major histocompatibility complex (MHC). Since autoantibody presence defines specific clinical subgroups of IIM, we aimed to correlate serotype and genotype, to identify novel risk variants in the MHC region that co-occur with IIM autoantibodies. METHODS: We collected available autoantibody data in our cohort of 2582 Caucasian patients with IIM. High resolution human leucocyte antigen (HLA) alleles and corresponding amino acid sequences were imputed using SNP2HLA from existing genotyping data and tested for association with 12 autoantibody subgroups. RESULTS: We report associations with eight autoantibodies reaching our study-wide significance level of p<2.9×10-5. Associations with the 8.1 ancestral haplotype were found with anti-Jo-1 (HLA-B*08:01, p=2.28×10-53 and HLA-DRB1*03:01, p=3.25×10-9), anti-PM/Scl (HLA-DQB1*02:01, p=1.47×10-26) and anti-cN1A autoantibodies (HLA-DRB1*03:01, p=1.40×10-11). Associations independent of this haplotype were found with anti-Mi-2 (HLA-DRB1*07:01, p=4.92×10-13) and anti-HMGCR autoantibodies (HLA-DRB1*11, p=5.09×10-6). Amino acid positions may be more strongly associated than classical HLA associations; for example with anti-Jo-1 autoantibodies and position 74 of HLA-DRB1 (p=3.47×10-64) and position 9 of HLA-B (p=7.03×10-11). We report novel genetic associations with HLA-DQB1 anti-TIF1 autoantibodies and identify haplotypes that may differ between adult-onset and juvenile-onset patients with these autoantibodies. CONCLUSIONS: These findings provide new insights regarding the functional consequences of genetic polymorphisms within the MHC. As autoantibodies in IIM correlate with specific clinical features of disease, understanding genetic risk underlying development of autoantibody profiles has implications for future research.
650    _2
$a dospělí $7 D000328
650    _2
$a alely $7 D000483
650    _2
$a autoprotilátky $x genetika $x imunologie $7 D001323
650    _2
$a běloši $x genetika $7 D044465
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a genotyp $7 D005838
650    _2
$a HLA-DRB1 řetězec $x genetika $x imunologie $7 D059811
650    _2
$a haplotypy $7 D006239
650    _2
$a lidé $7 D006801
650    _2
$a hlavní histokompatibilní komplex $x genetika $7 D008285
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a lidé středního věku $7 D008875
650    _2
$a myozitida $x genetika $x imunologie $7 D009220
650    _2
$a polymorfismus genetický $7 D011110
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Chinoy, Hector $u National Institute for Health Research Manchester Biomedical Research Centre, Central Manchester University Hospitals NHS Foundation Trust, Manchester, UK. Manchester Academic Health Science Centre, Salford Royal NHS Foundation Trust, Salford, UK.
700    1_
$a Lamb, Janine A $u Centre for Epidemiology, The University of Manchester, Manchester, UK.
700    1_
$a Miller, Frederick W $u Environmental Autoimmunity Group, National Institute of Environmental Health Sciences, Bethesda, Maryland, USA.
700    1_
$a Rider, Lisa G $u Environmental Autoimmunity Group, National Institute of Environmental Health Sciences, Bethesda, Maryland, USA.
700    1_
$a Wedderburn, Lucy R $u NIHR Great Ormond Street Biomedical Research Centre, University College London, London, UK. Arthritis Research UK Centre for Adolescent Rheumatology, University College London, London, UK.
700    1_
$a McHugh, Neil J $u Pharmacy and Pharmacology, University of Bath, Bath, UK.
700    1_
$a Mammen, Andrew L $u Muscle Disease Unit, Laboratory of Muscle Stem Cells and Gene Regulation, National Institute of Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, Maryland, USA. Departments of Neurology and Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
700    1_
$a Betteridge, Zoe E $u Pharmacy and Pharmacology, University of Bath, Bath, UK.
700    1_
$a Tansley, Sarah L $u Pharmacy and Pharmacology, University of Bath, Bath, UK. Royal National Hospital for Rheumatic Diseases, Royal United Hospitals Bath NHS Foundation Trust, Bath, UK.
700    1_
$a Bowes, John $u Arthritis Research UK Centre for Genetics and Genomics, The University of Manchester, Manchester, UK.
700    1_
$a Vencovský, Jiří $u Institute of Rheumatology and Department of Rheumatology, Charles University, Prague, Czech Republic.
700    1_
$a Deakin, Claire T $u NIHR Great Ormond Street Biomedical Research Centre, University College London, London, UK. Arthritis Research UK Centre for Adolescent Rheumatology, University College London, London, UK.
700    1_
$a Dankó, Katalin $u Internal Medicine, University of Debrecen, Debrecen, Hungary.
700    1_
$a Vidya, Limaye $u Rheumatology Unit, Royal Adelaide Hospital, University of Adelaide, Adelaide, South Australia, Australia.
700    1_
$a Selva-O'Callaghan, Albert $u Internal Medicine Department, Vall d'Hebron General Hospital, Universitat Autonoma de Barcelona, Barcelona, Spain.
700    1_
$a Pachman, Lauren M $u Ann & Robert H. Lurie Children's Hospital of Chicago, Northwestern University, Feinberg School of Medicine, Chicago, Illinois, USA.
700    1_
$a Reed, Ann M $u Pediatrics, Duke University, Durham, North Carolina, USA.
700    1_
$a Molberg, Øyvind $u Department of Rheumatology, University of Oslo, Oslo, Norway.
700    1_
$a Benveniste, Olivier $u Department of Internal Medicine and Clinical Immunology, Pitié-Salpêtrière University Hospital, France, France.
700    1_
$a Mathiesen, Pernille R $u Department of Paediatrics and Adolescent Medicine, Rigshospitalet, Copenhagen, Denmark.
700    1_
$a Radstake, Timothy R D J $u Department of Rheumatology and Clinical Immunology, Utrecht Medical Center, Utrecht, The Netherlands.
700    1_
$a Doria, Andrea $u Division of Rheumatology, University of Padova, Padova, Italy.
700    1_
$a de Bleecker, Jan $u Department of Neurology, Ghent University, Ghent, Belgium.
700    1_
$a Lee, Annette T $u Robert S. Boas Center for Genomics and Human Genetics, The Feinstein Institute for Medical Research, Manhasset, New York, USA.
700    1_
$a Hanna, Michael G $u MRC Centre for Neuromuscular Diseases, Department of Neuromuscular Diseases, University College London Institute of Neurology, London, UK.
700    1_
$a Machado, Pedro M $u Department of Rheumatology, University College London Hospital NHS Foundation Trust, London, UK. Department of Rheumatology, Northwick Park Hospital, London North West University Healthcare NHS Trust, London, UK.
700    1_
$a Ollier, William E $u Centre for Epidemiology, The University of Manchester, Manchester, UK. School of Healthcare Sciences, Manchester Metropolitan University, Manchester, Greater Manchester, UK.
700    1_
$a Gregersen, Peter K $u Center for Genomics and Human Genetics, The Feinstein Institute for Medical Research, Manhasset, New York, USA.
700    1_
$a Padyukov, Leonid $u Division of Rheumatology, Department of Medicine, Karolinska University Hospital, Stockholm, Sweden.
700    1_
$a O'Hanlon, Terrance P $u Environmental Autoimmunity Group, National Institute of Environmental Health Sciences, Bethesda, Maryland, USA.
700    1_
$a Cooper, Robert G $u MRC/ARUK Centre for Integrated Research into Musculoskeletal Ageing, University of Liverpool, Liverpool, Merseyside, UK.
700    1_
$a Lundberg, Ingrid E $u Division of Rheumatology, Department of Medicine, Karolinska University Hospital, Stockholm, Sweden.
710    2_
$a Myositis Genetics Consortium (MYOGEN)
773    0_
$w MED00000444 $t Annals of the rheumatic diseases $x 1468-2060 $g Roč. 78, č. 7 (2019), s. 996-1002
856    41
$u https://pubmed.ncbi.nlm.nih.gov/31138531 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20200511 $b ABA008
991    __
$a 20200518132539 $b ABA008
999    __
$a ok $b bmc $g 1525185 $s 1096383
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2019 $b 78 $c 7 $d 996-1002 $e 20190528 $i 1468-2060 $m Annals of the rheumatic diseases $n Ann Rheum Dis $x MED00000444
GRA    __
$a MR/K000608/1 $p Medical Research Council $2 United Kingdom
GRA    __
$a 20380 $p Arthritis Research UK $2 United Kingdom
GRA    __
$a MR/N003322/1 $p Medical Research Council $2 United Kingdom
GRA    __
$a 18474 $p Arthritis Research UK $2 United Kingdom
GRA    __
$a MR/S005021/1 $p Medical Research Council $2 United Kingdom
GRA    __
$a G0601943 $p Medical Research Council $2 United Kingdom
LZP    __
$a Pubmed-20200511

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...